Phoenix Biotech Acquisition Corp.
NASDAQ:PBAX
5.85 (USD) • At close February 14, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2025 Q1 | 2024 Q4 | 2024 Q3 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||
| Net Income
| -5.106 | -5.036 | -4.105 | -0.334 | -1.438 | -0.482 | -0.263 | 0.085 | -0.112 | -0.378 | -0.315 | -0.001 |
| Depreciation & Amortization
| 0.269 | 1.117 | 0.832 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0.305 | 0.097 | 0.079 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| 0 | -1.297 | -1.098 | 0.199 | 0.705 | 0.392 | 1.453 | 0.723 | 0.14 | 0.097 | -0.366 | 0.001 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Accounts Payables
| 0.728 | -0.377 | -0.6 | 0.165 | 1.129 | 0.364 | 0.943 | 0.547 | 0.042 | 0.107 | 0.013 | 0.001 |
| Other Working Capital
| 0 | 0.753 | 0.788 | 0.034 | -0.424 | -0.364 | 0.51 | 0.175 | 0.098 | -0.01 | -0.38 | 0 |
| Other Non Cash Items
| 0 | 0.666 | 0.543 | -0.122 | -0.151 | -0.109 | -1.563 | -0.982 | -0.265 | -0.027 | -0.016 | 0 |
| Operating Cash Flow
| -4.446 | -4.453 | -3.748 | -0.256 | -0.883 | -0.198 | -0.373 | -0.174 | -0.237 | -0.308 | -0.697 | 0 |
| Investing Activities: | ||||||||||||
| Investments In Property Plant And Equipment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | 0.444 | 0 | 0 | -0.275 | -0.1 | -0.325 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | -5.639 | 0 | 5.079 | 0.56 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | -0.679 | -0.185 | 5.689 | 0 | 0 | 181.036 | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow
| 0 | -5.874 | -0.185 | 5.689 | 0.285 | -0.1 | 180.711 | 0 | 0 | 0 | -178.5 | 0 |
| Financing Activities: | ||||||||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 0.717 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 5.639 | 0 | -5.639 | 0 | 0 | -139.354 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 5.605 | 0.572 | 0.572 | -5.419 | 0.525 | 0 | -138.704 | 0 | 0 | 0 | 0 | 0 |
| Financing Cash Flow
| 6.322 | 5.466 | 0.572 | -5.419 | 0.525 | 0 | -0 | 0 | 0 | 0 | 0 | 0 |
| Other Information: | ||||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0.016 | 0 | 0 | 0 | 0 | -138.704 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 1.876 | 1.482 | 2.457 | 0.014 | -0.073 | -0.298 | 41.634 | -0.046 | -0.237 | -0.308 | -179.197 | 0 |
| Cash At End Of Period
| 5.204 | 1.601 | 2.562 | 0.119 | 0.105 | 0.178 | 42.142 | 0.508 | 0.554 | 0.79 | 1.099 | 0 |